富国沪港深创新药产业ETF(159748)财务指标
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 本期已实现收益 |
-40,053,973.42 |
-25,497,530.26 |
-15,858,707.13 |
-4,893,159.73 |
| 本期利润 |
-41,349,521.19 |
-84,815,647.67 |
-31,241,605.43 |
-35,230,899.73 |
| 加权平均基金份额本期利润 |
-0.08 |
-0.17 |
-0.09 |
-0.12 |
| 本期加权平均净值利润率(%) |
-16.26 |
-33.44 |
-13.42 |
-17.18 |
| 本期基金份额净值增长率(%) |
-14.99 |
-28.59 |
-13.27 |
-15.19 |
| 期末可供分配利润 |
-213,815,592.65 |
-296,648,419.41 |
-174,891,555.22 |
-151,067,608.06 |
| 期末可供分配基金份额利润 |
-0.47 |
-0.55 |
-0.37 |
-0.38 |
| 期末基金资产净值 |
245,876,535.35 |
242,043,708.59 |
296,800,572.78 |
241,624,519.94 |
| 期末基金份额净值 |
0.53 |
0.45 |
0.63 |
0.62 |
| 基金份额累计净值增长率(%) |
-46.51 |
-55.07 |
-37.08 |
-38.47 |
微信公众号
证券之星APP
基本资料
